[Clinical analysis of seven cases with primary hyperoxaluria type 1 in children]

X Liao1, Y J Li1, F Zhong1

  • 1Department of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China.

Insights

Primary hyperoxaluria type 1 (PH1) in children, particularly the infantile form, presents with rapid progression and poor prognosis. Nephrocalcinosis is a key risk factor for renal failure, and delayed diagnosis remains a challenge.

Area of Science:

  • Pediatric Nephrology
  • Medical Genetics
  • Biochemistry

Background:

  • Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder characterized by excessive oxalate production.
  • Infantile PH1 often presents with severe renal disease and has a poor prognosis.
  • Understanding the phenotype-genotype correlation is crucial for early diagnosis and management.

Purpose of the Study:

  • To investigate the clinical, imaging, and molecular characteristics of pediatric PH1.
  • To summarize evidence for understanding the phenotype-genotype correlation in infantile PH1.
  • To identify risk factors for renal dysfunction in PH1.

Main Methods:

  • Retrospective analysis of medical records of children with PH1 diagnosed via gene testing.
  • Targeted exome and Sanger sequencing for genetic variant identification.
  • Logistic regression analysis to assess the relationship between nephrocalcinosis (NC) and renal function (creatinine clearance rate, CCr).
  • Literature review for comprehensive analysis.

Main Results:

  • Seven children from 6 families were studied, with a median onset age of 5 months.
  • Five patients progressed to end-stage renal disease (ESRD); four died.
  • Nephrocalcinosis (NC) was diagnosed in 5 cases, identified with high specificity by radiography.
  • NC was found to be an independent risk factor for renal dysfunction (OR 2.5, P<0.05).
  • All patients carried AGXT gene variants, with novel variants c.679_680delAA and c.190A>T identified.

Conclusions:

  • Infantile PH1 is the most common and aggressive form in children, with heterogeneous phenotypes and genotypes.
  • Nephrocalcinosis is a significant independent risk factor for renal failure in PH1.
  • Delayed diagnosis of PH1 is common in China, highlighting the need for improved diagnostic methods like quantitative oxalate determination.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
636
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
306
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
324
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184